Janssen, Alphapharm lay down swords in long-running battle over HIV drug patent
Intellectual Property 2019-05-06 12:03 pm | Melbourne
Drug maker Janssen will drop its long-running patent lawsuit against Alphapharm after the generic drug maker agreed to refrain from making products that allegedly infringe Janssen’s patents for its HIV drug Prezista.
For information on rights and reprints, contact subscriptions@lawyerly.com.au